@KevorkJan Not all primary care, but "single risk factor" thinking does persist. We found after lipid tests: If CVD risk wasn't coded (in 80%), the main predictor of statin prescribing was Total Chol. If CVD risk was coded (in 20%), the main predictor was
RT @TomPMarshall: We researched this. On 4/5 of occasions when lipids are checked, there is no record of a QRisk & the main predictor of pr…
RT @TomPMarshall: We researched this. On 4/5 of occasions when lipids are checked, there is no record of a QRisk & the main predictor of pr…
RT @TomPMarshall: We researched this. On 4/5 of occasions when lipids are checked, there is no record of a QRisk & the main predictor of pr…
When a QRISK2 score is coded, prescribing is more consistent with guidelines. With no QRISK2 score, prescribing is mainly based on total cholesterol. Using QRISK2 is associated w/ statin prescribing that is more likely 2 benefit pts, via @TomPMarshall &
RT @TomPMarshall: We researched this. On 4/5 of occasions when lipids are checked, there is no record of a QRisk & the main predictor of pr…
RT @TomPMarshall: We researched this. On 4/5 of occasions when lipids are checked, there is no record of a QRisk & the main predictor of pr…
We researched this. On 4/5 of occasions when lipids are checked, there is no record of a QRisk & the main predictor of prescribing is total cholesterol. On the other 1/5 of occasions, there's a record of a QRisk & risk is the main predictor of pres
RT @sfinnikin: Applying RRRs to baseline risk estimates (using QRISK2 for example) allows us to estimate a personalised ARR which is much m…
Applying RRRs to baseline risk estimates (using QRISK2 for example) allows us to estimate a personalised ARR which is much more accurate than a pooled ARR from studies. This is what we should be doing already (we don't always...) https://t.co/6esjt5QxFU
RT @TomPMarshall: @Ailsawalt @PharmRJ We found in most cases there was no record of CVD risk being calculated: so no answer even to 1) Whe…
@Ailsawalt @PharmRJ We found in most cases there was no record of CVD risk being calculated: so no answer even to 1) When there was a record of CVD risk, the decisions were twice as likely to be aligned to guideline recommendations. https://t.co/kapZ4VJk
@dnunan79 @alex_freeman @LoaiAlbarqouni @justsaysrisks As you know, I've spent a lot of time looking at statin initiation decisions. We have ways of estimating risks and benefits but my research suggests these aren't being used routinely https://t.co/3Cp0u
@pash22 @JDodsonMD @alf_collins @RichardLehman1 @glynelwyn @janewilcock @CatherineThomp8 @drtimwilson @dr_benoy_n_shah @mmamas1973 How often are decision aids used? Bear in mind that we found risk scores weren’t even calculated after most lipid tests. No
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
RT @BJGPjournal: Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK…
Cardiovascular disease: When a QRISK2 score is coded, statin prescribing is more consistent with guidelines. With no QRISK2 score, prescribing is mainly based on total cholesterol @sfinnikin @TomPMarshall @UoB_IAHR https://t.co/29dC5R7Z9I https://t.co/TWMx
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
Factors predicting statin prescribing for primary prevention: an historical cohort study https://t.co/dpgIPr3vMj via @sfinnikin & @TomPMarshall et al
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
RT @sfinnikin: *New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hop…
Congratulations Sam!!
*New Research* It's been 4 years in the making; and I'm really proud of this work. I think it's fascinating and useful. Hope you agree: https://t.co/oF2eQsdRcg
RT @TomPMarshall: It's the QRisk! GPs who calculate QRisk scores are twice as likely to follow statin guidelines (less undertreatment, les…
RT @TomPMarshall: It's the QRisk! GPs who calculate QRisk scores are twice as likely to follow statin guidelines (less undertreatment, les…
It's the QRisk! GPs who calculate QRisk scores are twice as likely to follow statin guidelines (less undertreatment, less overtreatment) QRisk calculated: 85% guideline compliant Not calculated: 44% guideline compliant https://t.co/GK92tKK9fp
@RichardLehman1 @drjohnm @ProfDFrancis @stephensenn @PWGTennant @EpiEllie @RogueRad ....see our paper which has just been made available: https://t.co/oF2eQsdRcg If QRISK is used the decision making is better.
RT @sfinnikin: @andyhersh @drmarkporter @joannabircherQI @amirhannan @louisebrady17 @parthaskar Update: Pre-print now available (thanks @BJ…
@andyhersh @drmarkporter @joannabircherQI @amirhannan @louisebrady17 @parthaskar Update: Pre-print now available (thanks @BJGPjournal ) https://t.co/oF2eQsdRcg Take a look...